ArticleOncotarget2018

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.

Man Kit Siu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.